AGP Executive Report
Last update: 4 hours agoPrecision Oncology Coverage: Malaysia’s Malayan Re and China Re Life signed a reinsurance treaty to back a new framework for cancer precision medicine, including CAR-T and targeted therapies, with overseas treatment benefits for policyholders. Ebola Response in DRC: The DRC announced free healthcare for all illnesses in Ituri as Ebola cases and deaths rise, with doubled risk allowances for doctors in the response. Hospital Accountability in UK: Nottinghamshire police arrested two men over mortuary service misconduct at Nottingham University Hospitals ahead of a major independent maternity review. Medicare Osteoporosis Test: Medicare will reimburse a new osteoporosis screening method using biomechanical CT, starting Oct. 5, 2026, with retroactive coverage to Jan. 1, 2024. Pharma M&A: AbbVie agreed to buy Apogee Therapeutics for $10.9B to expand immunology, while Sun Pharma will acquire Innovcare Lifesciences for about Rs 271.2 crore. Drug Safety: FDA recalled chlorthalidone blood pressure tablets over failed dissolution specs, citing possible ineffectiveness. Public Health & Access: Kenya’s Pharmacy and Poisons Board arrested 95 fake pharmacists and shut 48 unlicensed premises in a Nairobi-region crackdown. Clinical Pipeline Moves: Prime Medicine got FDA RMAT for PM359 in chronic granulomatous disease; Praxis Precision Medicines earned Breakthrough Therapy for elsunersen in SCN2A-related seizures. Healthcare Under Strain: UK heatwave concerns echoed by NHS A&E pressure and hospital overheating risks.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
